George Georges
Endocrinology, Diabetes & Metabolism · Richmond, VANPI 1700173481
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in VA, where the typical reported total is $1,187.
Across 51 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$116
- Shire North American Group Inc$96
- Lilly USA, LLC$79
- Abbott$67
- Amgen$61
- Johnson & Johnson$57
- plus $382 from 18 others
What the payments were for
- Food & beverage$857100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $116 |
| Shire North American Group Inc | 6 | $96 |
| Lilly USA, LLC | 5 | $79 |
| Abbott | 3 | $67 |
| Amgen | 3 | $61 |
| Johnson & Johnson | 4 | $57 |
| AstraZeneca | 3 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Valeritas, Inc. | 2 | $35 |
| Pfizer | 2 | $29 |
| BD | 1 | $24 |
| Merck | 2 | $24 |
| IBSA Pharma Inc. | 1 | $18 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| AbbVie | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Insulet Corporation | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
How this compares
$857 in reported general payments places this provider in the 40th percentile of 223 endocrinology, diabetes & metabolism providers in Virginia.
See all endocrinology, diabetes & metabolism providers in Virginia →
Other endocrinology, diabetes & metabolism in Richmond
- Shea PuttkammerRichmond$24K
- Robert AdlerRichmond$10K
- Ranjodh GillRichmond$8K
- Robert CastellucciRichmond$7K
- Farhad ZangenehSterling$1.2M
- James MulindaRoanoke$788K
- Jeffrey SicatGlen Allen$657K
- Dewey BaileyRoanoke$645K
- Domenica RubinoArlington$608K
- Samamtha HudsonMidlothian$372K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.